Business expansion through the development of new products, technologies and markets
First written in FY2016. 19 of 32 entries say "Advanced", first in FY2020. Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Regarding growth investment, the Company incurred ¥668 million in capital expenditures, mainly in the metal surface treatment agents and equipment, etc. segment, and ¥1,273 million in R&D investment, mainly in the same segment, during the current consolidated fiscal year. For the next consolidated fiscal year, the Company expects capital expenditures of ¥1,904 million and R&D investment of ¥1,427 million.」
The company disclosed specific results and plans, having invested ¥1,273 million in research and development and expecting to invest ¥1,427 million in the following fiscal year. This is up from the previous fiscal year's ¥1,186 million. - FY2026-H1AdvancedAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥621 million.」
Discloses that the Company continued its R&D investment and incurred ¥621 million during the current interim consolidated accounting period. This was an increase from ¥578 million in the same period of the previous year. - FY2025AdvancedAnnual report
「Regarding growth investment, the Company incurred ¥735 million in capital expenditures, mainly in the metal surface treatment agents and equipment, etc. segment, and ¥1,186 million in R&D investment, mainly in the same segment, during the current consolidated fiscal year. For the next consolidated fiscal year, the Company expects capital expenditures of ¥707 million and R&D investment of ¥1,315 million.」
Discloses specific actual and planned amounts for R&D investment: ¥1,186 million incurred during the current consolidated fiscal year and ¥1,315 million expected in the next fiscal year. - FY2025-H1AdvancedAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥578 million.」
Discloses that the Company continued its R&D investment and incurred ¥578 million during the current interim consolidated accounting period. - FY2024-Q3AdvancedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥860 million.」
Discloses that the Company continued its R&D investment and incurred ¥860 million during the third quarter of the current consolidated cumulative period. - FY2024-Q2AdvancedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥565 million.」
Discloses R&D expenses of ¥565 million incurred during the second quarter of the current consolidated cumulative period as the Company continued its R&D investment aimed at developing new products, technologies and markets. - FY2024-Q1AdvancedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥275 million.」
Discloses that the Company continued its R&D investment and incurred ¥275 million during the first quarter of the current consolidated cumulative period. - FY2023AdvancedAnnual report
「Regarding growth investment, the Company incurred ¥394 million in capital expenditures, mainly in the metal surface treatment agents and equipment, etc. segment, and ¥1,096 million in R&D investment, mainly in the same segment, during the current consolidated fiscal year. For the next consolidated fiscal year, the Company expects capital expenditures of ¥1,064 million and R&D investment of ¥1,210 million.」
Discloses specific actual and planned amounts for R&D investment: ¥1,096 million incurred during the current consolidated fiscal year and ¥1,210 million expected in the next consolidated fiscal year. - FY2023-Q3AdvancedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥816 million.」
Discloses that the Company continued its R&D investment and incurred ¥816 million during the third quarter of the current consolidated cumulative period. - FY2023-Q2AdvancedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥538 million.」
Discloses that the Company continued its R&D investment and incurred ¥538 million during the second quarter of the current consolidated cumulative period. - FY2023-Q1AdvancedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥267 million.」
Discloses that the Company continued its R&D investment and incurred ¥267 million during the first quarter of the current consolidated cumulative period. - FY2022-Q3AdvancedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥790 million.」
Discloses R&D expenses of ¥790 million incurred during the third quarter of the current consolidated cumulative period, providing a specific amount that demonstrates the continuation of the investment. - FY2022-Q2AdvancedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥525 million.」
Discloses R&D expenses of ¥525 million incurred during the second quarter of the current consolidated cumulative period, providing a specific amount for continued R&D investment aimed at developing new products, technologies and markets. - FY2022-Q1AdvancedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥259 million.」
Discloses that the Company continued its R&D investment and incurred ¥259 million during the first quarter of the current consolidated cumulative period. - FY2021AdvancedAnnual report
「Regarding growth investment, the Company incurred ¥273 million in capital expenditures, mainly in the metal surface treatment agents and equipment, etc. segment, and ¥1,076 million in R&D investment, mainly in the same segment, during the current consolidated fiscal year. For the next consolidated fiscal year, the Company expects capital expenditures of ¥428 million and R&D investment of ¥1,143 million.」
Discloses specific actual and planned amounts for R&D investment: ¥1,076 million incurred during the current consolidated fiscal year and ¥1,143 million expected in the next consolidated fiscal year. - FY2021-Q3AdvancedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥823 million.」
With regard to the policy of developing new products, technologies and markets through R&D investment, discloses R&D expenses of ¥823 million incurred during the third quarter of the current consolidated cumulative period. - FY2021-Q2AdvancedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥544 million.」
With regard to the policy of developing new products, technologies and markets through R&D investment, discloses R&D expenses of ¥544 million incurred during the second quarter of the current consolidated cumulative period. - FY2021-Q1AdvancedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥286 million.」
With regard to the policy of developing new products, technologies and markets through R&D investment, discloses R&D expenses of ¥286 million incurred during the first quarter of the current consolidated cumulative period. - FY2020AdvancedAnnual report
「The total R&D expenses incurred by the Group during the consolidated fiscal year were ¥1,041 million.」
Discloses total R&D expenses of ¥1,041 million for the fiscal year, providing a specific amount invested in developing new products, technologies and markets through R&D investment. R&D investment of ¥1,042 million is budgeted for fiscal 2020. - FY2020-Q2RestatedAnnual report
「(a) We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2020-Q1RestatedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2019RestatedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment. - FY2019-Q3RestatedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2019-Q2RestatedAnnual report
「(a) We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2019-Q1RestatedAnnual report
「(a) We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2018-Q3RestatedAnnual report
「(a) We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2018-Q1RestatedAnnual report
「(a) We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2017RestatedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the policy of developing new products, technologies and markets through R&D investment. - FY2017-Q3RestatedAnnual report
「(a) We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2017-Q2RestatedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the initiative of developing new products, technologies and markets through R&D investment and expanding the scope of the business. - FY2017-Q1RestatedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
Restates the policy of developing new products, technologies and markets through R&D investment. - FY2016First statedAnnual report
「We will actively invest in R&D to develop new products and technologies, and develop new products and markets to expand the scope of our business.」
First appearance. This is presented in multiple places as a means of growth through the development of new products, technologies and markets via R&D investment.